Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04010695 · ClinicalTrials.gov registry record · NA
Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US
A NA study, sponsored by PATH.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT04010695 is a NA study that has completed, run by PATH. The registered enrollment target is 250 participants.
The verdict
NCT04010695, a NA study, has completed, sponsored by PATH.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the accuracy of the SD Biosensor STANDARD G6PD Analyzer in measuring G6PD activity when used by trained health care workers.
Interventions
- DIAGNOSTIC_TEST Pointe Scientific Test Kit
- DIAGNOSTIC_TEST HemoCue System
- DIAGNOSTIC_TEST SD Biosensor G6PD Analyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2019-05-13 |
| Est. Completion | 2019-09-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04010695
The ClinicalTrials.gov registry entry for NCT04010695 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PATH, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Pointe Scientific Test Kit is the first listed.
NCT04010695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04010695 about?
NCT04010695 is a clinical study titled "Validation of Diagnostics to Identify Glucose-6-phosphate Dehydrogenase Activity in the US". The primary objective of this study is to assess the accuracy of the SD Biosensor STANDARD G6PD Analyzer in measuring G6PD activity when used by trained health care workers.
What is the current status of trial NCT04010695?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2019-05-13. Estimated completion is 2019-09-19.
What interventions are being tested in trial NCT04010695?
The interventions under investigation include: Pointe Scientific Test Kit (DIAGNOSTIC_TEST), HemoCue System (DIAGNOSTIC_TEST), SD Biosensor G6PD Analyzer (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04010695?
This trial is sponsored by PATH, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.